Literature DB >> 1729258

Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.

M Landström1, J E Damber, A Bergh, R Tomic.   

Abstract

The present study was undertaken to investigate to what extent the oestrogen-induced effects on growth and morphology of the Dunning R3327 rat prostatic adenocarcinoma are dose-dependent. Castrated and testosterone-supplemented rats were used in order to study effects of increasing doses of oestrogens on the tumour. It was found that the lowest dose of oestradiol-17 beta that reduced the overall growth, the volume density of the epithelium and epithelial cell area in Dunning R3327 prostatic tumours is 10 micrograms given as daily injections. Higher oestrogen doses (50 micrograms, 200 micrograms, and 500 micrograms), in addition to reducing the volume of tumour epithelium, also induced an increase of the volume density of tumour stroma. The area of stroma cell nuclei was increased by 50 micrograms and 200 micrograms oestradiol-17 beta. These observation, may indicate that the lowest effective oestrogen dose is different in the epithelium and stroma of Dunning tumours and that large doses of oestrogen stimulate the stromal compartment. This stimulatory effect did not influence the inhibitory effects seen on the overall growth of the tumour and on the tumor epithelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729258     DOI: 10.1007/bf01192308

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

Review 1.  Actions of estrogen in the male.

Authors:  M G Mawhinney; B L Neubauer
Journal:  Invest Urol       Date:  1979-05

2.  PROSTATE CANCER IN THE RAT.

Authors:  W F DUNNING
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

3.  Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. III. Effects of estrogens on the growth of the tumor tissue.

Authors:  G J van Steenbrugge; M Groen; A van Kreuningen; F H de Jong; M P Gallee; F H Schröder
Journal:  Prostate       Date:  1988       Impact factor: 4.104

Review 4.  Endocrine control and physiology of the prostate.

Authors:  A A Sandberg
Journal:  Prostate       Date:  1980       Impact factor: 4.104

5.  Physiologic basis for hormonal theapy in carcinoma of the prostate.

Authors:  P C Walsh
Journal:  Urol Clin North Am       Date:  1975-02       Impact factor: 2.241

6.  Induction of nuclear androgen-binding sites in epithelium of the embryonic urinary bladder by mesenchyme of the urogenital sinus of embryonic mice.

Authors:  G R Cunha; B A Reese; M Sekkingstad
Journal:  Endocrinology       Date:  1980-12       Impact factor: 4.736

7.  The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer.

Authors:  J T Isaacs
Journal:  Prostate       Date:  1984       Impact factor: 4.104

8.  A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.

Authors:  D L Citrin; M S Kies; C B Wallemark; J Khandekar; E Kaplan; F Camacho; R Lind
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

9.  Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.

Authors:  B G Mobbs; I E Johnson
Journal:  J Steroid Biochem       Date:  1985-01       Impact factor: 4.292

10.  The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.

Authors:  M R Schneider; A Humm; A H Graf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

View more
  1 in total

1.  Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.

Authors:  J E Damber; A Bergh; B Assarsson; M Gåfvels
Journal:  Urol Res       Date:  1995
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.